Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
07/13/2006 | WO2006021833A3 Bisbenzamidines for the treatment of pneumonia |
07/13/2006 | WO2004078908A3 Alpha-keto carbonyl calpain inhibitors |
07/13/2006 | US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, |
07/13/2006 | US20060154933 Inhibitors of Cdc25 phosphatases |
07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
07/13/2006 | CA2594098A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
07/13/2006 | CA2592909A1 Imidazole derivatives as enzyme reverse transcriptase modulators |
07/12/2006 | EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative |
07/12/2006 | EP1679302A1 Aromatic amino acid labeled with stable isotope, method for incorporating the same into target protein and method for analyzing protein structure using nmr |
07/12/2006 | EP1679069A1 Novel piperidine derivative |
07/12/2006 | EP1678133A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
07/12/2006 | EP1678128A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
07/12/2006 | EP1678121A2 Tao kinase modulators and methods of use |
07/12/2006 | EP1222163B1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
07/12/2006 | CN1802715A Electrolytic solution for electrochemical element, method of searching for the same, method of producing the same, and electrochemical element |
07/12/2006 | CN1802368A Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
07/12/2006 | CN1800184A Synthesis of temozolomide and analogs |
07/12/2006 | CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production |
07/12/2006 | CN1800167A Anaerobe resistant compound |
07/12/2006 | CN1800166A Ornidazole optical antimer preparation and purification method |
07/12/2006 | CN1800165A Cationic symmetric 2-imidazolium diazo compounds with a cationic linking group, compositions comprising them, a dying process and kit thereof |
07/12/2006 | CN1263750C Heterocyclic sulfonamide inhibitors from beta amyloid |
07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
07/12/2006 | CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels |
07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
07/11/2006 | US7074937 Method for production of additives for lubricating oils |
07/11/2006 | US7074934 Serine protease inhibitors |
07/11/2006 | US7074923 Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof |
07/11/2006 | US7074921 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds |
07/11/2006 | US7074867 Ion conducting polymers |
07/11/2006 | US7074820 Amidino derivatives and their use as thrombin inhibitors |
07/11/2006 | US7074786 Histogranin-like peptides, processes for their preparation and uses thereof |
07/11/2006 | US7074594 A full-length cDNA encoding a human-derived G protein-coupled receptor protein is isolated by screening a human hippocampus library; lows intracellular cAMP concentration under stimulation with histamine; usable for screening ligands or in screening candidate compounds for drugs |
07/11/2006 | CA2367306C New cycloheptene compounds, their preparation process and the pharmaceutical compounds containing them |
07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
07/06/2006 | WO2006070545A1 Ionic liquid |
07/06/2006 | US20060149074 Method for the production of purified 1,3-substituted imidazolium salts |
07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
07/06/2006 | US20060149066 Imidazole derivatives |
07/06/2006 | US20060149051 Method of preparing an acylimidazolium-type reagent |
07/06/2006 | US20060148875 Agent for prophylaxis and treatment of diabetic complications |
07/06/2006 | US20060148874 Compounds for use in the treatment of aids and other viral diseases and HIV-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
07/06/2006 | US20060148872 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one |
07/06/2006 | US20060148779 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives |
07/06/2006 | DE102004060076A1 Verfahren zur Herstellung von Onium-Salzen mit Alkyl- oder Arylsulfonat-Anionen oder Alkyl- oder Arylcarboxylat-Anionen mit geringem Halogenid-Gehalt A process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content |
07/06/2006 | DE102004060075A1 Verfahren zur Herstellung von Onium-Salzen mit Dialkylphosphat-, Dialkylphosphinat oder (O-Alkyl)-alkyl- oder Alkyl-phosphonat-Anionen mit geringem Halogenid-Gehalt A process for the preparation of onium salts with dialkylphosphate, or dialkyl phosphinate (O-alkyl) alkyl or alkyl-phosphonate anions with low halide content |
07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
07/05/2006 | EP1675833A1 1h-imidazole derivatives as cannabinoid receptor modulators |
07/05/2006 | EP1613604B1 1-imidazolylmethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing |
07/05/2006 | EP1467744A4 Aqueous compositions containing metronidazole |
07/05/2006 | EP1371649B1 Process for producing 5-substituted oxazole and 1,5-disubstituted imidazole compounds |
07/05/2006 | CN1798735A 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
07/05/2006 | CN1262547C Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
07/05/2006 | CN1262543C Method for producing hydantoin of intermediate of sweeting agent |
07/04/2006 | US7071358 Lipid diseases; metabolism diosrders; antiproliferative agents |
07/04/2006 | US7071350 Method of introducing amino group and method of synthesizing amino acid compound |
07/04/2006 | US7071231 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
07/04/2006 | US7071220 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents |
07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
07/04/2006 | US7070630 Primary intermediates for oxidative coloration of hair |
07/04/2006 | US7070626 Oxidative coloring agents for keratin fibers |
07/04/2006 | CA2250840C Antivirally active heterocyclic azahexane derivatives |
07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
06/29/2006 | WO2006067428A2 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
06/29/2006 | WO2006067139A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
06/29/2006 | WO2006066790A1 Tetralin and indane derivatives and uses thereof |
06/29/2006 | US20060142612 Arylsulfonamide derivatives |
06/29/2006 | US20060142586 Synthesis of 2-alkyl amino acids |
06/29/2006 | US20060142366 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
06/29/2006 | US20060142363 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
06/29/2006 | US20060142362 Pyrazoles, triazoles, or tetrazoles substituted with an aryl- or heteroarylcarbonylamino group and an aminocarbonylmethyl group: 5-chloro-thiophene-2-carboxylic acid (1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-1H-[1,2,4]triazol-3-yl)-amide; improved selectivity towards thrombin |
06/29/2006 | US20060142296 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
06/29/2006 | US20060142252 Tubulin binding agents and corresponding prodrug constructs |
06/29/2006 | US20060142209 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
06/29/2006 | US20060141395 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
06/29/2006 | DE102004060247A1 New N-heterocyclic carbene radical compounds useful as e.g. catalysts in organocatalysis; and ligands in transition metal catalysts in homogeneous catalysis |
06/29/2006 | DE102004060229A1 Neue zyklische Harnstoffe als Inhibitoren von Metallproteasen New cyclic ureas as inhibitors of metalloproteases |
06/29/2006 | DE102004060074A1 Verfahren zur Herstellung von Onium Alkylsulfaten mit geringem Halogenid-Gehalt A process for the preparation of onium alkylsulfates with low halide content |
06/29/2006 | DE102004060073A1 Producing onium tetrafluoroborates useful as ionic liquids comprises reacting an onium halide with a trialkyloxonium, trialkylsulfonium or triphenylcarbonium tetrafluoroborate |
06/29/2006 | CA2591937A1 Tetralin and indane derivatives and uses thereof |
06/29/2006 | CA2588028A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
06/28/2006 | EP1673356A1 Substituted benzylaminoalkylene heterocycles |
06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
06/28/2006 | EP1301829A4 Radiation sensitive compositions containing image quality and profile enhancement additives |
06/28/2006 | CN1795179A Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
06/28/2006 | CN1795178A Process for synthesizing heterocyclic compounds |
06/28/2006 | CN1793150A Diene silicoxyane linking disbenzocyclobutylene monomer and process for preparing prepolymer |
06/28/2006 | CN1793128A Anti anaerbic bacterial compound |
06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
06/27/2006 | US7067551 Deacetylase inhibitors |
06/27/2006 | US7067542 Diaminediols for the treatment of Alzheimer's disease |
06/27/2006 | US7067539 Cannabinoid receptor ligands |
06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |